Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1990-9-11
pubmed:abstractText
Two models of murine graft-versus-host disease (GVHD) were studied with respect to autoantibody production and development of systemic lupus erythematosus (SLE) like disease. One model was induced by injection of (B10.A(4R) x B10.A(2R]F1 mice with parental (B10.A(4R] spleen and lymph node cells (groups I GVHD), the other by injection of (DBA/2 x C57/B16)F1 mice with DBA/2 cells (group II GVHD). Group I GVHD mice remained in a seemingly healthy condition and did not show any proteinuria, in spite of high titres of anti-nuclear antibodies including antibodies to dsDNA, anti-Sm and anti-ribosomal P protein antibodies. Measured levels of these autoantibodies as well as their isotypes were comparable with those found in MRL/lpr and NZB/W mice. Group II GVHD mice developed SLE-like disease signs, including severe proteinuria. At 4 months after induction of the GVHD, almost 50% of these mice had died. At the time nephritis was present, group II mice also produced anti-dsDNA and anti-nuclear antibodies of other (unknown) specificities, but no anti-Sm or anti-P. Furthermore, the incidence of these antibodies was lower than observed in group I GVHD, MRL/lpr or NZB/W mice. It is concluded that (high avidity) anti-dsDNA as well as anti-Sm and anti-P may be present in the circulation without giving rise to the development of nephritis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-1084750, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-2302829, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-2410526, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-2429305, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-2452189, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-2453555, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-2781137, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-304883, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-316537, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-3372998, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-3491700, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-3496538, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-3498593, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-3532863, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-3794348, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-3877758, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-388439, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-3890479, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-4085147, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-4969617, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-5124390, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-52321, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-6182766, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-6183348, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-6966403, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-6978376, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-6978818, http://linkedlifedata.com/resource/pubmed/commentcorrection/2379320-7007509
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
81
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
31-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Fine specificities of anti-nuclear antibodies in murine models of graft-versus-host disease.
pubmed:affiliation
Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
pubmed:publicationType
Journal Article